The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant pertuzumab, docetaxel, carboplatin, and trastuzumab (PTCH) regimen in patients with HER2 positive early, locally advanced, and oligometastatic breast cancer: Real-world Indian experience.
 
Ajay Gogia
No Relationships to Disclose
 
Anshul Gupta
No Relationships to Disclose
 
Atul Batra
Stock and Other Ownership Interests - Caplin Point Laboratories; Glenmark; Laurus; Zydus Pharmaceuticals
Research Funding - Alkem Laboratories; Astellas Pharma; AstraZeneca
 
S.V.S Deo
No Relationships to Disclose
 
Ashutosh Mishra
No Relationships to Disclose
 
Daya Nand Sharma
No Relationships to Disclose
 
Surendra Kumar Saini
No Relationships to Disclose
 
Sandeep Mathur
No Relationships to Disclose
 
Hari Krishna Raju Sagiraju
Research Funding - Bayer India
 
Chandra Prakash Prasad
No Relationships to Disclose